HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

637.736

+19.0313.08%

Number of Gainers:22

Number of Losers:8

Number of Flat:4

PE:- -

High:646.735

Open:618.980

Low:611.252

Close:618.706

Volume:128.20M

Turnover:4.02B

Market Cap:394.17B

Float Cap:350.94B

Loading ...

HK Stock Buyback Summary | October 31

China Securities: Breakthroughs in Oligonucleotide Therapeutics Showcase Global Competitiveness of Chinese Biotech Firms

Dermagnus Pharma Submits Listing Application to HKEX, Ranks First in Dermatology Prescription Drug Revenue Among China's Innovative Pharma Firms

U.S. Stock Movement | Moderna (MRNA.US) Surges Over 9% Amid Acquisition Talks with Major Pharma

Market Plunge: Optical Modules and Biotech Stocks Adjust, ETFs Attract Heavy Inflows; Lithium Stocks Lead Nonferrous Metals Rally with 159876 Up Over 1%

Ping An Fund's Zhou Sicheng: Biotech Adjustment Continues, But Three-Year Bull Trend Remains Intact

Visual Guide to REMEGEN's Q3 2025 Earnings Report

Pharmaceutical Innovation Investment Conference Held in Nanjing; HKEX: Hong Kong Regains Status as Top Listing Destination for Biotech Firms

ZYLOXTB (02190) Repurchased 50,000 Shares for HK$1.19 Million on October 30

REMEGEN (09995) Reports Q3 Results: Net Loss Narrows 48.6% YoY to RMB 551 Million

HBM HOLDINGS-B (02142) Repurchases 100,000 Shares for HK$1.33 Million on October 30

Pia Automation Successfully Debuts at IHMD China International High-End Medical Equipment Forum, Showcasing New Pathways for Smart Medical Manufacturing

HBM Holdings Files HKEX Disclosure on Repurchase of 100,000 Shares for HKD 1,333,250

JD HEALTH Launches Over 20 New Medical Devices This Year, 11.11 Sales Surge Over 100% YoY

JW Cayman Therapeutics Signs Amendment to Collaboration Agreement with Regeneron

Great Wall Fund's Healthcare Investment Team Eyes Potential Second Wave in Pharma Sector

Fuling District Market Supervision Bureau Strengthens Implementation of Online Medical Device Sales Quality Management Standards

HBM HOLDINGS-B (02142) Rises Over 4% After Launching First Fully Human HCAb Generation Model to Accelerate Next-Gen Therapies

EVEREST MED (01952) Secures Exclusive Rights to Ophthalmic Bispecific Drug VIS-101, Entering $40 Billion Blue Ocean Market

2025 National Medical Insurance Negotiations Kick Off with Introduction of "Commercial Insurance Innovative Drug List" Mechanism

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1574/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":637.73645,"timestamp":1762157288176,"preClose":618.7055,"halted":0,"volume":128198934,"delay":0,"changeRate":0.030759,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":19.030945,"latestTime":"11-03 16:00:00","open":618.97986,"high":646.73535,"low":611.2518,"amount":4019731835,"amplitude":0.057351,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1762219800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762133400000,1762142400000],[1762146000000,1762156800000]],"pbRate":5.343409,"peRate":-44.036334,"turnoverRate":0.004676,"increases":23,"decrements":8,"flats":2,"marketCap":394165077952,"floatMarketCap":350938497872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":646.73535,"amplitude":0.057351,"preClose":618.7055,"low":611.2518,"pbRate":"5.343409","latestPrice":637.73645,"volume":128198934,"delay":0,"open":618.97986,"prevYearClose":331.1933,"prevWeekClose":618.706,"prevMonthClose":618.706,"prevQuarterClose":752.859,"fiveDayClose":617.318,"twentyDayClose":766.012,"sixtyDayClose":789.562,"secType":"PLATE","market":"HK","turnoverRate":0.004676,"peRate":-44.036334,"marketCap":394165077952,"floatMarketCap":350938497872,"timestamp":1762157288176,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":22,"down":8,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197902130","title":"HK Stock Buyback Summary | October 31","url":"https://stock-news.laohu8.com/highlight/detail?id=1197902130","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197902130?lang=en_us&edition=fundamental","pubTime":"2025-10-31 09:12","pubTimestamp":1761873166,"startTime":"0","endTime":"0","summary":"On October 30, 2025, multiple Hong Kong-listed companies conducted share buybacks. Among them, China Feihe (06186) executed the largest buyback, repurchasing 12 million shares for HKD 50.23 million....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1149","LU0211977185.USD","02299","HK0000320264.USD","LU0307460666.USD","BK1619","LU0228659784.USD","09890","LU1282651048.USD","BK1542","00386","BK1593","BK1549","LU0259732245.USD","06826","BK1226","LU2045819591.USD","LU0048580855.USD","LU0823426308.USD","BK1137","06868","LU1023057109.AUD","LU1439103000.SGD","BK1606","LU0650527681.SGD","BK1506","LU0737861699.HKD","BK1161","LU2097828714.EUR","LU0173614495.USD","00103","LU0072462343.USD","IE00B0169L03.USD","LU0672654166.SGD","LU0163747925.USD","LU0359201885.HKD","LU0359202008.SGD","LU1048596156.SGD","HK0000306701.USD","IE00B067MR52.USD","HK0000306685.HKD","00947","02142","LU2097828474.EUR","LU0463099449.HKD","LU1224709979.USD","LU2097828805.USD","BK1219","BK1607","LU0471298777.SGD","LU0651947912.USD","IE0008369823.USD","00909","BK1155","LU0181495838.USD","LU0370786039.SGD","BK1597","LU0326950275.SGD","LU1102505929.USD","LU0651946864.USD","LU0128522157.USD","LU1769817096.USD","BK1151","LU0348788117.USD","02319","LU1048588211.SGD","02190","01497","BK1583","02869","BK1599","01167","LU0228367735.SGD","IE0008368742.USD","LU0359201612.USD","SG9999011746.SGD","LU2125910500.SGD","IE00B031J352.USD","BK1500","BK1553","BK1575","LU0821914370.USD","BK1516","BK1225","01583","00418","SG9999002828.SGD","BK1117","LU0029875118.USD","01373","02598","BK1518","BK1100","IE00B031HY20.USD","06098","09959","IE0032834883.USD","02120","LU0106959298.USD","LU0293314216.USD","02273","BK1170","BK1253","BK1201","LU1102505762.USD","LU0823426480.USD","LU0140636845.USD","01519","BK1574","LU0588546209.SGD","02416","LU1051768304.USD","LU1769817179.HKD","LU1515016050.SGD","BK1618","BK1521","HK0000320223.HKD","IE0009570106.USD","BK1209","LU0328353924.USD","BK1109","IE00B97KM107.HKD","00732","02486","01681","02005","BK1587","LU0251143458.SGD","LU0287142896.SGD","LU0543330483.HKD","BK1589","LU0594300419.USD","BK1160","BK1191","IE00B29SXG58.USD","06186","LU2097828631.EUR","LU2097828557.USD","LU1188198961.HKD","BK1158","LU0828237940.HKD","LU1831875114.USD","BK1258","BK1528","LU1051769294.HKD","LU0348805143.USD","BK1229","LU2460026573.USD","LU0320764755.SGD","LU0315179316.USD","LU0385154629.USD","BK1562","BK1237","LU0244354667.USD","IE0031814852.USD","08128"],"gpt_icon":0},{"id":"1117852557","title":"China Securities: Breakthroughs in Oligonucleotide Therapeutics Showcase Global Competitiveness of Chinese Biotech Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1117852557","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117852557?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:48","pubTimestamp":1761868105,"startTime":"0","endTime":"0","summary":"China Securities Co., Ltd. released a research report highlighting oligonucleotide therapeutics as the potential third major drug class after small molecules and antibodies, owing to their ability to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601066","06978","159992","BK0276","BK1574","BK1161"],"gpt_icon":0},{"id":"1167617063","title":"Dermagnus Pharma Submits Listing Application to HKEX, Ranks First in Dermatology Prescription Drug Revenue Among China's Innovative Pharma Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1167617063","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167617063?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:14","pubTimestamp":1761866065,"startTime":"0","endTime":"0","summary":"Dermagnus Pharma Limited (Dermagnus Pharma) has submitted a listing application to the Hong Kong Stock Exchange (HKEX) main board, with Huatai International acting as the sole sponsor. According to a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159992","HEXmain","BK1515","BK1574","06978","159938","BK1161"],"gpt_icon":0},{"id":"1138187374","title":"U.S. Stock Movement | Moderna (MRNA.US) Surges Over 9% Amid Acquisition Talks with Major Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1138187374","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138187374?lang=en_us&edition=fundamental","pubTime":"2025-10-30 23:50","pubTimestamp":1761839417,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA.US) saw its shares rise sharply on Thursday, climbing over 9% to $26.95 at the time of writing. The surge follows reports that the company is engaged in acquisition discussions...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4548","BK4533","BK4585","BK1574","01477","BK4501","BK4532","BK4568","BK4588","BK4534","BK1191","BK4551","BK4139"],"gpt_icon":0},{"id":"1194698305","title":"Market Plunge: Optical Modules and Biotech Stocks Adjust, ETFs Attract Heavy Inflows; Lithium Stocks Lead Nonferrous Metals Rally with 159876 Up Over 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194698305","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194698305?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:30","pubTimestamp":1761823856,"startTime":"0","endTime":"0","summary":"On Thursday (October 30), A-shares experienced a volatile correction, with all three major indices plunging intraday. The ChiNext Index fell nearly 2%, while the Shanghai Composite Index dropped...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4550","BK4585","159876","159992","FDN","BK4588","06978","BK1161"],"gpt_icon":0},{"id":"1172456032","title":"Ping An Fund's Zhou Sicheng: Biotech Adjustment Continues, But Three-Year Bull Trend Remains Intact","url":"https://stock-news.laohu8.com/highlight/detail?id=1172456032","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172456032?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:23","pubTimestamp":1761823420,"startTime":"0","endTime":"0","summary":"Ping An Fund's portfolio manager Zhou Sicheng recently analyzed the logic behind the ongoing biotech sector correction and shared her outlook during a live-streamed event. She noted that the current...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1574","BK1161","06978"],"gpt_icon":0},{"id":"1175668652","title":"Visual Guide to REMEGEN's Q3 2025 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1175668652","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175668652?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:11","pubTimestamp":1761822688,"startTime":"0","endTime":"0","summary":"For comprehensive data and in-depth analysis, visit the Sina Finance app.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","688331","LU1064130708.USD","LU2328871848.SGD","LU2488822045.USD","LU1064131003.USD","LU2148510915.USD","BK1161","09995","BK1574","LU1969619763.USD","BK0239"],"gpt_icon":0},{"id":"1155112449","title":"Pharmaceutical Innovation Investment Conference Held in Nanjing; HKEX: Hong Kong Regains Status as Top Listing Destination for Biotech Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1155112449","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155112449?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:00","pubTimestamp":1761822046,"startTime":"0","endTime":"0","summary":"The 10th China Pharmaceutical Innovation and Investment Conference, jointly organized by HKEX (00388) and the China Pharmaceutical Innovation and Development Association, was successfully held in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0043850808.USD","LU0359202008.SGD","LU1807302812.USD","LU1282649810.SGD","LU0106959298.USD","LU0791591158.USD","LU0594300179.USD","LU0979878070.USD","LU2039709279.SGD","LU0197773673.USD","LU0762540952.USD","LU0067412154.USD","LU0165289439.USD","SG9999002562.SGD","LU0048580855.USD","LU0320764599.SGD","LU0314109678.HKD","SG9999004220.SGD","LU0516423174.USD","LU0791590937.USD","LU0630378429.USD","LU1282649141.HKD","LU0918141887.USD","LU1993786604.SGD","LU1282649067.USD","BK1515","LU0577902611.USD","LU1328277881.USD","LU0048597586.USD","LU0577902371.SGD","LU0634319403.HKD","SG9999002463.SGD","LU0348827113.USD","LU0169518387.USD","LU1366334578.USD","LU0955669360.SGD","LU1481107354.HKD","LU0348814723.USD","LU0149721374.USD","LU0648948544.HKD","SG9999001846.SGD","09939","LU0918141705.HKD","LU0651946864.USD","LU0607220059.USD","LU0096374516.USD","HEXmain","LU0456846285.SGD","LU0516422952.EUR","LU0831103253.SGD","LU0164880469.USD","LU1105468828.SGD","LU2257852520.SGD","LU0594300419.USD","BK1589","LU0488056044.USD","LU1044874839.SGD","LU0370786039.SGD","LU0197773160.USD","LU0577902454.USD","LU0384037296.USD","80388","LU1211504680.USD","LU0819123356.HKD","159938","SGXZ90724238.SGD","BK1610","LU0348735423.USD","LU2226246903.HKD","LU0762542818.HKD","LU0955648018.USD","LU0061477393.USD","HKXCY","159837","LU1130305938.SGD","LU1515016050.SGD","LU0955623706.USD","LU0196878994.USD","LU0572944931.SGD","LU1226287529.USD","BK1521","BK1161","LU0211977185.USD","LU0651947912.USD","LU0577902538.SGD","BK1574","IE00BKZH1Z71.USD","LU1366334651.USD","LU1048588211.SGD","SG9999001051.SGD","LU0605514214.HKD","LU0856984785.SGD","LU2449936058.SGD","IE00BZ08YT58.USD","LU0821914370.USD","LU1831875114.USD","LU0348825331.USD","LU0072462343.USD","LU0359201885.HKD","LU0084288322.USD","LU1642822792.SGD","LU1048596156.SGD","BK1131","LU0762541174.USD","LU0516422440.USD","LU0873338254.USD","LU0072913022.USD","LU0052750758.USD","LU0359201612.USD","LU0417516738.SGD","LU0831093199.SGD","SG9999001093.SGD","LU0117841782.USD","LU1044875133.USD","LU1504937902.USD","LU1981816686.USD","LU0417516902.SGD","LU0540923850.HKD","IE00BZ08YR35.GBP","LU0630378692.HKD","00388","LU0140636845.USD","LU0261947096.USD","LU1242518857.USD","LU1051768304.USD","IE00B3T34201.USD","LU1242518931.SGD","LU0886674414.USD","LU0516423091.SGD","LU0327786744.USD","LU0577902298.EUR","LU0650527681.SGD","LU0149534421.HKD","LU0708995583.HKD","LU1813983027.USD","LU0251144936.SGD","LU0501845795.SGD","LU1051769294.HKD","LU0516422366.SGD","LU1023057109.AUD","LU0348816934.USD","LU1044876610.USD","LU1282648689.USD","LU0898667661.SGD","LU1734074674.USD","LU0561508036.HKD","LU0797268264.HKD","LU0819121731.USD","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"1102890640","title":"ZYLOXTB (02190) Repurchased 50,000 Shares for HK$1.19 Million on October 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1102890640","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102890640?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:51","pubTimestamp":1761821489,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) announced that it repurchased 50,000 shares for HK$1.19 million on October 30, 2025.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"1183751009","title":"REMEGEN (09995) Reports Q3 Results: Net Loss Narrows 48.6% YoY to RMB 551 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1183751009","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183751009?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:14","pubTimestamp":1761819261,"startTime":"0","endTime":"0","summary":"REMEGEN (09995) announced its financial results for the first three quarters of 2025, with revenue reaching approximately RMB 1.72 billion, a year-on-year increase of 42.27%. The net loss...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","LU2148510915.USD","BK1583","LU1969619763.USD","688331","LU1064130708.USD","BK1574","BK1161","BK0239","LU2488822045.USD","LU2328871848.SGD","LU1064131003.USD"],"gpt_icon":0},{"id":"1105722954","title":"HBM HOLDINGS-B (02142) Repurchases 100,000 Shares for HK$1.33 Million on October 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1105722954","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105722954?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:10","pubTimestamp":1761819035,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) announced that the company repurchased 100,000 shares on October 30, 2025, at a price range of HK$13.11 to HK$13.46 per share, totaling approximately HK$1.33 million.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"1157205372","title":"Pia Automation Successfully Debuts at IHMD China International High-End Medical Equipment Forum, Showcasing New Pathways for Smart Medical Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=1157205372","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157205372?lang=en_us&edition=fundamental","pubTime":"2025-10-30 18:02","pubTimestamp":1761818563,"startTime":"0","endTime":"0","summary":"Ningbo Pia Automation Holding Corp. (688306) made a successful debut at the IHMD China International High-End Medical Equipment Forum, presenting innovative solutions for the advancement of smart...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","159883","159891","688306","BK1222","09997","BK1100","09996","BK1583","BK1574"],"gpt_icon":0},{"id":"2579611379","title":"HBM Holdings Files HKEX Disclosure on Repurchase of 100,000 Shares for HKD 1,333,250","url":"https://stock-news.laohu8.com/highlight/detail?id=2579611379","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579611379?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:50","pubTimestamp":1761817814,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of 100,000 shares at an aggregate price of HKD 1,333,250. These shares are being held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL88dM95:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02142","BK1161","BK1574"],"gpt_icon":0},{"id":"1133999426","title":"JD HEALTH Launches Over 20 New Medical Devices This Year, 11.11 Sales Surge Over 100% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1133999426","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133999426?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:41","pubTimestamp":1761817303,"startTime":"0","endTime":"0","summary":"On October 30, JD HEALTH announced during a media event with Yuwell Medical that it has introduced more than 20 new medical devices this year as a global online launch platform. These include...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1247","BK1515","09996","BK1574","LU0456827905.SGD","06618","BK1222","BK1589","BK1100","BK1571","LU0051755006.USD","SGXZ62798434.SGD","159883","BK1615","BK1591","09997","BK1583","86618","SGXZ86797644.SGD"],"gpt_icon":1},{"id":"2579118214","title":"JW Cayman Therapeutics Signs Amendment to Collaboration Agreement with Regeneron","url":"https://stock-news.laohu8.com/highlight/detail?id=2579118214","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579118214?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:34","pubTimestamp":1761816870,"startTime":"0","endTime":"0","summary":"JW Cayman Therapeutics Co. Ltd. announced a major transaction involving Amendment No. 1 to its Collaboration Agreement. The amendment, dated October 30, 2025, involves JW Cayman, JW Shanghai, and Regeneron. Under the terms of the amendment, Regeneron has agreed to fund certain development activities related to the MAGE-A4 Product, including making an upfront payment to the company. The collaboration agreement was originally established between JW Cayman and 2seventy bio on October 27, 2022, and was assigned to Regeneron effective April 1, 2024.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Cayman Therapeutics Co. Ltd. published the original content used to generate this news brief on October 30, 2025, and is solely responsible for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL39sr0q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BK4585","LU2023250504.SGD","LU2362541513.USD","LU2106854487.HKD","LU2362541273.HKD","LU0882574055.USD","BK4139","BK1583","BK4588","LU0058720904.USD","LU0320765992.SGD","BK1161","LU0823434740.USD","LU0109394709.USD","LU1974910355.USD","LU2468319806.SGD","LU2362540622.SGD","LU0823434583.USD","LU2237438978.USD","BK1574","LU1917777945.USD","LU0889565916.HKD","LU0289739699.SGD","02126","LU0053666078.USD","REGN","LU0114720955.EUR","LU0823416689.USD"],"gpt_icon":0},{"id":"1156751703","title":"Great Wall Fund's Healthcare Investment Team Eyes Potential Second Wave in Pharma Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1156751703","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156751703?lang=en_us&edition=fundamental","pubTime":"2025-10-30 16:51","pubTimestamp":1761814283,"startTime":"0","endTime":"0","summary":"Currently, China's economic fundamentals remain stable, with policies entering a critical window period. Meanwhile, the external environment is complex, as the trajectory of U.S.-China trade...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"1199736295","title":"Fuling District Market Supervision Bureau Strengthens Implementation of Online Medical Device Sales Quality Management Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=1199736295","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199736295?lang=en_us&edition=fundamental","pubTime":"2025-10-30 13:31","pubTimestamp":1761802286,"startTime":"0","endTime":"0","summary":"In recent days, the Fuling District Market Supervision Bureau in Chongqing has taken multiple measures to actively promote and implement the \"Online Medical Device Sales Quality Management Standards\"...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","09997","09996","159883","BK1222","BK1100","BK1574"],"gpt_icon":0},{"id":"1145278677","title":"HBM HOLDINGS-B (02142) Rises Over 4% After Launching First Fully Human HCAb Generation Model to Accelerate Next-Gen Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=1145278677","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145278677?lang=en_us&edition=fundamental","pubTime":"2025-10-30 11:08","pubTimestamp":1761793695,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) surged more than 4%, reaching HK$13.49 by the time of writing, with a trading volume of HK$52.54 million. The company announced the launch of its Hu-mAtrIx™ AI-powered fully...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1583","02142"],"gpt_icon":0},{"id":"1167592945","title":"EVEREST MED (01952) Secures Exclusive Rights to Ophthalmic Bispecific Drug VIS-101, Entering $40 Billion Blue Ocean Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1167592945","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167592945?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:42","pubTimestamp":1761792176,"startTime":"0","endTime":"0","summary":"On October 30, Hong Kong-listed biopharmaceutical company EVEREST MED (01952) announced an agreement with Visara to obtain exclusive rights for the clinical development, production, and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","BK4585","01952","BK1583","VIS","BK1574"],"gpt_icon":0},{"id":"1156670626","title":"2025 National Medical Insurance Negotiations Kick Off with Introduction of \"Commercial Insurance Innovative Drug List\" Mechanism","url":"https://stock-news.laohu8.com/highlight/detail?id=1156670626","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156670626?lang=en_us&edition=fundamental","pubTime":"2025-10-30 10:20","pubTimestamp":1761790838,"startTime":"0","endTime":"0","summary":"The 2025 National Medical Insurance Negotiations commenced in Beijing on October 30. This year’s negotiations mark the first official introduction of the \"Commercial Insurance Innovative Drug List\"...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159992","06978"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":4,"totalSize":233,"code":"91000000","status":"200"}]}}